August 11, 2014

Sanofi on Monday acquired the rights to Afrezza Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with Type 1 and Type 2 diabetes, from MannKind in a deal that could be worth as much as $925 million. 

August 8, 2014

The Food and Drug Administration earlier this week announced approval for Orbactiv (oritavancin), an antibacterial drug used to treat patients with acute bacterial skin and skin structure infections.

August 8, 2014

The BBC on Tuesday reported that a team has developed an app and small lens add-on that allows blood-cell analysis via a smartphone.

August 7, 2014

A new experimental drug to treat Ebola has been tried in the two American patients being treated in an Atlanta hospital, The New York Times reported Wednesday

August 6, 2014

BD Medical, a segment of BD, on Wednesday announced the retail pharmacy launch of BD AutoShield Duo, the only pen needle with patented dual front- and back-end shields that provides greater convenience and safety before and after injecting. 

August 5, 2014

BioCSL on Tuesday announced that it has started shipping the seasonal influenza vaccine Afluria for the 2014-15 flu season.

August 5, 2014

One-in-four Americans admits that they have misused prescription drugs, according to a new national survey by FindLaw.com.

 

August 4, 2014

The Pennsylvania House of Representatives unanimously adopted House Resolution 938, which designates August as National Immunization Awareness Month, the legislature announced Monday.

August 1, 2014

The Food and Drug Administration announced approval for Boehringer Ingelheim's Jardiance tablets.

August 1, 2014

The Food and Drug Administration approved Striverdi Respimat (olodaterol) inhalation spray for the treatment of chronic obstructive pulmonary disease, including chronic bronchitis and/or in patients with emphysema that are experiencing airflow obstruction, the agency announced.

July 31, 2014

McKesson on Thursday reported revenues of $44.1 billion for the first quarter ended June 30, up 37%. 

July 30, 2014

Pfizer on Wednesday announced that it has entered into a definitive agreement to acquire Baxter International’s portfolio of marketed vaccines for $635 million.

July 30, 2014

GSK announced that Tanzeum (albiglutide), a once-weekly, prescription injectable treatment for Type 2 diabetes in adults, is now available in pharmacies throughout the United States.

July 28, 2014

The Food and Drug Administration on Monday expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia who carry a deletion in chromosome 17.

July 28, 2014

Reckitt Benckiser announced the company will be looking to spin off its pharma business in the next 12 months. 

 

July 24, 2014

The Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), a long-acting opioid analgesic.

July 24, 2014

Onco360, an independent oncology pharmacy and clinical support services company, announced that it has been selected to be part of the highly limited specialty pharmacy network of Zydelig tablets.

July 23, 2014

The first batch of vaccines for the upcoming flu season is on its way to pharmacies, hospitals and doctors offices.

July 21, 2014

Innocutis on Monday announced the introduction of Sitavig (acyclovir) 50-mg buccal tablet into North American markets.

July 21, 2014

Sandoz on Monday announced an agreement with Anacor Pharmaceuticals to obtain exclusive rights to commercialize Kerydin (tavaborole) topical solution, 5%, through its branded dermatology business, PharmaDerm.

July 21, 2014

Teva Pharmaceutical Industries on Monday announced that its acquistion of Labrys has been completed. The acquisition brings to Teva LBR-101, which is currently in phase-2b clinical trials for prevention of chronic and episodic migraines.

July 18, 2014

The Food and Drug Administration on Thursday announced the approval of Ruconest, a recombinant C1-Esterase inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema.

July 17, 2014

Purdue Pharma announced that the Food and Drug Administration approved a new 7.5-mcg/hour dosage strength of Butrans (buprenorphine) transdermal system CIII.

July 16, 2014

GSK has begun shipping Fluarix Quadrivalent (influenza vaccine) doses to U.S. healthcare providers, the company annouced. This marks the first shipment of GSK's U.S. flu vaccine supply for the flu season, which follows licensing and lot-release approval from the Food and Drug Administration's Center for Biologics Evaluation and Research.